MA27204A1 - Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci - Google Patents

Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci

Info

Publication number: MA27204A1
Authority: MA; Morocco
Prior art keywords: medicament; reagent; preparation; diagnostic; substituted thiophenes
Prior art date: 2002-06-04

Application number

MA27952A

Other languages

English (en)

Inventor

Hans-Jochen Lang

Uwe Heinelt

Armin Hofmeister

Klaus Wirth

Michael Gekle

Markus Bleich

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-04

Filing date

2004-11-16

Publication date

2005-01-03

2004-11-16 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

2005-01-03 Publication of MA27204A1 publication Critical patent/MA27204A1/fr

Links

239000003814 drug Substances 0.000 title 2
239000003153 chemical reaction reagent Substances 0.000 title 1
229930192474 thiophene Natural products 0.000 title 1
150000003577 thiophenes Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Diabetes (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Toxicology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)

MA27952A 2002-06-04 2004-11-16 Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci MA27204A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10224892A DE10224892A1 (de)	2002-06-04	2002-06-04	Substituierte Thiophene, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number	Publication Date
MA27204A1 true MA27204A1 (fr)	2005-01-03

Family

ID=29557542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27952A MA27204A1 (fr)	2002-06-04	2004-11-16	Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci

Country Status (32)

Country	Link
EP (1)	EP1513834B1 (fr)
JP (1)	JP4511924B2 (fr)
KR (1)	KR101087966B1 (fr)
CN (1)	CN1324024C (fr)
AR (1)	AR040239A1 (fr)
AT (1)	ATE320425T1 (fr)
AU (1)	AU2003273553B2 (fr)
BR (1)	BR0311548A (fr)
CA (1)	CA2488242C (fr)
CR (1)	CR7577A (fr)
DE (2)	DE10224892A1 (fr)
DK (1)	DK1513834T3 (fr)
EC (1)	ECSP045471A (fr)
ES (1)	ES2258722T3 (fr)
HR (1)	HRP20041153A2 (fr)
IL (1)	IL165519A (fr)
MA (1)	MA27204A1 (fr)
ME (1)	MEP27608A (fr)
MX (1)	MXPA04011986A (fr)
MY (1)	MY129832A (fr)
NO (1)	NO329351B1 (fr)
OA (1)	OA12827A (fr)
PE (1)	PE20040534A1 (fr)
PL (1)	PL372589A1 (fr)
PT (1)	PT1513834E (fr)
RS (1)	RS51141B (fr)
RU (1)	RU2315766C2 (fr)
TN (1)	TNSN04240A1 (fr)
TW (1)	TWI283675B (fr)
UA (1)	UA77551C2 (fr)
WO (1)	WO2003101984A1 (fr)
ZA (1)	ZA200409095B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040242560A1 (en)	2003-05-22	2004-12-02	Aventis Pharma Deutschland Gmbh	Process for synthesizing heterocyclic compounds
DE10323701A1 (de)	2003-05-22	2004-12-23	Aventis Pharma Deutschland Gmbh	Verfahren zur Synthese heterocyclischer Verbindungen
CN1839116B (zh)	2003-06-30	2010-05-26	住友化学株式会社	不对称脲化合物和通过用其作催化剂的不对称共轭加成反应制备不对称化合物的方法
WO2008051533A2 (fr) *	2006-10-25	2008-05-02	Takeda Pharmaceutical Company Limited	Composés de benzimidazole
CA2735842A1 (fr)	2008-09-02	2010-03-11	Sanofi-Aventis	Aminoindanes substitues, leurs analogues, et leur utilisation pharmaceutique
RU2373929C1 (ru) *	2008-11-11	2009-11-27	Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА)	Корректор системы гемостаза, проявляющий ингибирующее действие на адгезивно-агрегационную функцию тромбоцитов для профилактики патологического тромбообразования
JP2013510824A (ja) *	2009-11-12	2013-03-28	セルビタエス．エー．	セリン／トレオニンキナーゼを調節または制御するための化合物、その調製のための方法、医薬組成物、化合物の使用、方法ならびにセリン／トレオニンキナーゼ調節剤
RU2518740C1 (ru) *	2013-03-22	2014-06-10	Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ"	СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ДИГИДРОХЛОРИД 2-(3,4-МЕТИЛЕНДИОКСИФЕНИЛ)-9-МОРФОЛИНОЭТИЛИМИДАЗО[1,2-a]БЕНЗИМИДАЗОЛА
PT3173408T (pt)	2014-07-25	2019-02-12	Taisho Pharmaceutical Co Ltd	Composto de fenil tetra-hidroisoquinolina substituído com heteroarilo
KR102840252B1 (ko) *	2023-04-27	2025-07-30	한국화학연구원	시아노벤즈이미다졸 유도체, 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물
CN120112529B (zh) *	2023-09-28	2026-01-06	四川大学华西医院	一种含吡啶的化合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE754935A (fr) *	1969-08-13	1971-02-17	Hoechst Ag	2-(thienyl-3'-amino)-1,3-diazacycloalcenes et leur preparation
BR6915362D0 (pt) *	1969-08-16	1973-01-04	Hoechst Ag	Processo para a preparacao de 2(tienil-3-amino)1,3-diazacicloalquenos
DE2830279A1 (de) *	1978-07-10	1980-01-31	Boehringer Sohn Ingelheim	2-eckige klammer auf n-(2'-chlor-4'- methyl-thienyl-3')-n-(cyclopropylmethyl)- amino eckige klammer zu-imidazolin-(2), dessen saeureadditionssalze, dieses enthaltende arzneimittel und verfahren zu seiner herstellung
US5395847A (en) *	1993-12-02	1995-03-07	Smithkline Beecham Corporation	Imidazolyl-alkenoic acids
JP2002521450A (ja) *	1998-07-29	2002-07-16	メルクエンドカムパニーインコーポレーテッド	インテグリン受容体アンタゴニスト
DE19921883A1 (de) *	1999-05-12	2000-11-16	Bayer Ag	Substituierte Thienocycloalk(en)ylamino-1,3,5-triazine
DE19960204A1 (de) *	1999-12-14	2001-06-28	Aventis Pharma Gmbh	Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
IL164302A0 (en) *	2002-03-29	2005-12-18	Chiron Corp	Substituted benzazoles and use thereof as raf kinase inhibitors

2002
- 2002-06-04 DE DE10224892A patent/DE10224892A1/de not_active Withdrawn
2003
- 2003-05-26 DK DK03740148T patent/DK1513834T3/da active
- 2003-05-26 BR BR0311548-8A patent/BR0311548A/pt not_active IP Right Cessation
- 2003-05-26 KR KR1020047019725A patent/KR101087966B1/ko not_active Expired - Fee Related
- 2003-05-26 OA OA1200400321A patent/OA12827A/en unknown
- 2003-05-26 WO PCT/EP2003/005465 patent/WO2003101984A1/fr not_active Ceased
- 2003-05-26 ES ES03740148T patent/ES2258722T3/es not_active Expired - Lifetime
- 2003-05-26 HR HR20041153A patent/HRP20041153A2/xx not_active Application Discontinuation
- 2003-05-26 JP JP2004509675A patent/JP4511924B2/ja not_active Expired - Fee Related
- 2003-05-26 CN CNB038128462A patent/CN1324024C/zh not_active Expired - Fee Related
- 2003-05-26 ME MEP-276/08A patent/MEP27608A/xx unknown
- 2003-05-26 RS YUP-1038/04A patent/RS51141B/sr unknown
- 2003-05-26 PL PL03372589A patent/PL372589A1/xx not_active Application Discontinuation
- 2003-05-26 CA CA2488242A patent/CA2488242C/fr not_active Expired - Fee Related
- 2003-05-26 AT AT03740148T patent/ATE320425T1/de active
- 2003-05-26 RU RU2004138812/04A patent/RU2315766C2/ru not_active IP Right Cessation
- 2003-05-26 UA UA20041211000A patent/UA77551C2/uk unknown
- 2003-05-26 AU AU2003273553A patent/AU2003273553B2/en not_active Ceased
- 2003-05-26 EP EP03740148A patent/EP1513834B1/fr not_active Expired - Lifetime
- 2003-05-26 PT PT03740148T patent/PT1513834E/pt unknown
- 2003-05-26 MX MXPA04011986A patent/MXPA04011986A/es active IP Right Grant
- 2003-05-26 DE DE50302673T patent/DE50302673D1/de not_active Expired - Lifetime
- 2003-05-30 PE PE2003000531A patent/PE20040534A1/es not_active Application Discontinuation
- 2003-06-02 TW TW092114860A patent/TWI283675B/zh not_active IP Right Cessation
- 2003-06-02 AR ARP030101958A patent/AR040239A1/es active IP Right Grant
- 2003-06-03 MY MYPI20032052A patent/MY129832A/en unknown
2004
- 2004-11-10 ZA ZA200409095A patent/ZA200409095B/xx unknown
- 2004-11-16 MA MA27952A patent/MA27204A1/fr unknown
- 2004-11-19 CR CR7577A patent/CR7577A/es unknown
- 2004-12-02 IL IL165519A patent/IL165519A/en not_active IP Right Cessation
- 2004-12-02 EC EC2004005471A patent/ECSP045471A/es unknown
- 2004-12-03 TN TNP2004000240A patent/TNSN04240A1/en unknown
- 2004-12-16 NO NO20045504A patent/NO329351B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU2003273553B2 (en)	2008-12-04
HRP20041153A2 (en)	2005-06-30
MY129832A (en)	2007-05-31
IL165519A0 (en)	2006-01-15
RU2004138812A (ru)	2005-07-20
EP1513834B1 (fr)	2006-03-15
DK1513834T3 (da)	2006-07-17
BR0311548A (pt)	2005-04-12
KR20050005532A (ko)	2005-01-13
WO2003101984A1 (fr)	2003-12-11
JP2005533038A (ja)	2005-11-04
TW200406409A (en)	2004-05-01
HK1076460A1 (en)	2006-01-20
JP4511924B2 (ja)	2010-07-28
PE20040534A1 (es)	2004-10-25
NO20045504L (no)	2005-01-25
UA77551C2 (en)	2006-12-15
CN1324024C (zh)	2007-07-04
EP1513834A1 (fr)	2005-03-16
PL372589A1 (en)	2005-07-25
IL165519A (en)	2010-05-31
CN1659163A (zh)	2005-08-24
DE10224892A1 (de)	2003-12-18
ZA200409095B (en)	2005-05-10
TWI283675B (en)	2007-07-11
CA2488242A1 (fr)	2003-12-11
NO329351B1 (no)	2010-10-04
OA12827A (en)	2006-07-11
TNSN04240A1 (en)	2007-03-12
ATE320425T1 (de)	2006-04-15
CR7577A (es)	2005-06-16
MEP27608A (en)	2010-06-10
PT1513834E (pt)	2006-06-30
MXPA04011986A (es)	2005-03-07
DE50302673D1 (de)	2006-05-11
RS103804A (sr)	2006-12-15
ES2258722T3 (es)	2006-09-01
AR040239A1 (es)	2005-03-23
ECSP045471A (es)	2005-01-28
RS51141B (sr)	2010-10-31
KR101087966B1 (ko)	2011-12-01
RU2315766C2 (ru)	2008-01-27
AU2003273553A1 (en)	2003-12-19
CA2488242C (fr)	2011-08-02

Publication	Publication Date	Title
BR9703161A (pt)	1998-09-29	Cromanos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos
BR0210006A (pt)	2004-08-10	Produto absorvente descartável
MA27147A1 (fr)	2005-01-03	4-phenyltetrahydro-isoquinoleines substituees, procede pour leur preparation, leur utilisation en tant que medicament, et medicament les contenant
MA27204A1 (fr)	2005-01-03	Thiophenes substitues, procede de preparation de ceux-ci, utilisation en tant que medicament ou reactif diagnostique, et medicament contenant ceux-ci
MA27252A1 (fr)	2005-03-01	Diphenylazetidinones substituees, leur procede de preparation, medicaments contenant ces composes et leur utilisation
IL150228A0 (en)	2002-12-01	Substituted norbornylamino derivatives, method for the production thereof, use thereof as medicament or a diagnostic reagent and medicaments containing said compounds
IL165213A0 (en)	2005-12-18	Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilizationmedicament or diagnostic agent and medicament containing same
NO972433L (no)	1997-12-01	Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
TR199600400A2 (tr)	1997-03-21	Ikame edilmis benziloksikarbonil-guanidinler, bunlarin elde edilmesine iliskin yöntem, ilac veya teshis maddesi olarak kullanilmasi veya bu maddeleri ihtiva eden ilaclar.
NO964053D0 (no)	1996-09-26	Substituerte benzoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
ID17038A (id)	1997-12-04	Orto-benzoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya
BR0011586B1 (pt)	2008-11-18	processo e dispositivo para a fabricaÇço de um produto a partir de uma fita adesiva, em particular um produto que contÉm uma substÂncia ativa e/ou medicinal.
NO983577L (no)	1999-02-08	Sulfonamidsubstituerte forbindelser, fremgangsmÕter for deres fremstilling, deres anvendelse som medikament eller diagnostikum, samt medikament inneholdende forbindelsen
BR9605568A (pt)	1998-08-18	Benzoilguanidinas substituídas por sulfonilamino processo para a sua preparaçao seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
NO972434D0 (no)	1997-05-28	Substituerte 1-naftoylguanidiner, fremgangsmåte for fremstilling derav, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
MA27171A1 (fr)	2005-01-03	Dihydro-thia-phenanthrene-darbonyl-guanidines, procede de production desdites substances et leur utilisation en tant que medicament ou produit de diagnostic, et medicament contenant lesdites substances
ID17321A (id)	1997-12-18	Orto-benzoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya.
MA28161A1 (fr)	2006-09-01	Les pentafluorosulfanylbenzoylguanidines, leur procédé de production, leur utilisation comme médicaments ou agents de diagnostic et les médicaments les contenant
IL162562A (en)	2009-12-24	Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis and drug containing substituted imidazolidines
HRP980066B1 (en)	2002-06-30	Sulfonamide substituted compounds, processes for their preparation, their use as medicins or diagnostic agents as well as the medicine containing them
EP1515960A4 (fr)	2006-07-26	Derive de 2-thioxothiazole, procede de preparation de ce derive et composition pharmaceutique contenant ce derive
HUP0204095A3 (en)	2005-05-30	Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and pharmaceutical compositions containing the same
EP1515952A4 (fr)	2007-06-06	Derive pyrazole-3-one, son procede de preparation et composition pharmaceutique le contenant
ID16042A (id)	1997-08-28	Orto-benzoilguanidin tersubstitusi, proses untuk pembuatannya, pemakaiannya sebagai obat atau diagnostik, dan obat yang mengandungnya
SI1509498T1 (sl)	2007-04-30	Pentafluorosulfanil-benzoilgvanidini, postopek za njihovo pripravo, njihova uporaba kot zdravilo ali diagnosticno sredstvo in zdravilo, ki jih vsebuje